PSA Today Jan 28: Virus weighs / Regenerative medicine stocks / Canon squeezing Canon Electronics / JSR's life sciences / FY19 Q3 Fanuc preview + a look at Daikin – Nikkei -0.55%
Japan Market Comment by Pelham Smithers, Joel Scheiman and William NestukNikkei ¥23,215.71 (-¥370.86 / -0.55%); Topix ¥1,725.05 (-¥27.56 / -1.62%); ¥/$109.03
Tags: Daiwabo (3107 JT), Shionogi (4507 JT), Koa Corp (6999 JT), Nitto Denko (6988 JT), JSR Corp (4185 JT), Koei Tecmo (3635 JT), Nidec (6594 JT), Reprocell (4978 JT), Cellseed (7776 JT), Shin-Etsu Chemical (4063 JT), Obic (4684 JT), Hitachi Chemical (4217 JT), Hitachi (6501 JT), Showa Denko (4004 JT), Canon Electronics (7739 JT), Canon (7751 JT), Canon Marketing (8060 JT), Taiwan Semiconductor Mfg. Co. (2330 TT), Intel (INTC US), KBI Biopharma (pvt.), Coherus BioSciences (CHRS US), Amgen (AMGN US), Sandoz (Novartis company), Novartis (NOVN SW), Innovent Biologics (1801 HK), Roche Holding (ROG, SW), Fanuc (6954 JT), Yaskawa Electric (6506 JT), Daifuku (6383 JT), Fast Retailing (9983 JT), Toyota Motor (7203 JT)
Main Points
• Market weakness continues on coronavirus worries
• Canon puts the squeeze on Canon Electronics
• JSR’s life sciences maintain an upward trend
• FY19 Q3 Fanuc preview and a look at Daifuku
Founded in 2009, Pelham Smithers Associates (PSA) provides market intelligence on Asian technology, focusing in particular on Japan. The industries covered by our team of specialists are: consumer electronics, telecomms, pharmaceuticals, internet, electronic parts and materials, automotive technology, retail and capital goods.
PSA produces both company and sector reports. The focus of PSA’s research is to identify winners and losers as new technologies impact the top and bottom lines of corporations. Critical to our research is the clear explanation of how these new technologies work and how they impact companies and industries.
The founding partners have worked closely together for twenty years and the team has more than doubled in size since 2012.
Unfortunately, this report is not available for the investor type or country you selected.
Browse all ResearchPool reportsReport is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.